Elisabetta Metafuni

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Anne M. Spanjaart, Per Ljungman, Rafael de la Cámara et al. · Leukemia · 2021 · 116 citations · Full text

Medicine, Hematology, Infectious Diseases +16

Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients

Silvia Bellesi, Elisabetta Metafuni, Stefan Hohaus et al. · British Journal of Haematology · 2020 · 106 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation

Silvia Bellesi, Patrizia Chiusolo, Gennaro De Pascale et al. · Supportive Care in Cancer · 2012 · 61 citations

Medicine, Hematology, Oncology +14

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

Patrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi et al. · Cancer Chemotherapy and Pharmacology · 2011 · 47 citations

Medicine, Oncology, Pharmacology +15

Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with <scp>anti‐CD19 CAR‐T</scp> cells

Eugenio Galli, Federica Sorà, Stefan Hohaus et al. · British Journal of Haematology · 2022 · 45 citations · Full text

Life Sciences, Hematology, Immunology +17